dalteparin has been researched along with Diathesis in 5 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Excerpt | Relevance | Reference |
---|---|---|
"The risk of late thrombosis and pulmonary embolism is discussed from pathogenetic factors and data on frequencies of thromboembolic complications in the literature." | 3.78 | Prolonged prophylaxis against postoperative venous thromboembolism. ( Bergqvist, D, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goldsmith, DJ | 1 |
Vayá, A | 1 |
Mira, Y | 1 |
Aznar, J | 1 |
Todolí, J | 1 |
Arguedas, J | 1 |
Solá, E | 1 |
Puértolas Ortega, M | 1 |
Izquierdo Villarroya, B | 1 |
Oliva Perales, P | 1 |
Lafuente Ojeda, N | 1 |
Izquierdo Villarroya, J | 1 |
Ruiz Pérez, R | 1 |
Bergqvist, D | 1 |
Gilmore, G | 1 |
Thom, J | 1 |
Baker, RI | 1 |
2 reviews available for dalteparin and Diathesis
Article | Year |
---|---|
Enoxaparin-related fatal spontaneous retroperitoneal hematoma in the elderly.
Topics: Age Factors; Aged; Anticoagulants; Disease Susceptibility; Enoxaparin; Fatal Outcome; Female; Hemato | 2003 |
Prolonged prophylaxis against postoperative venous thromboembolism.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Disease Susceptibility; Double-Blind Method; Drug Ad | 1996 |
1 trial available for dalteparin and Diathesis
Article | Year |
---|---|
Prolonged prophylaxis against postoperative venous thromboembolism.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Disease Susceptibility; Double-Blind Method; Drug Ad | 1996 |
3 other studies available for dalteparin and Diathesis
Article | Year |
---|---|
Calciphylaxis, thrombotic diathesis and defects in coagulation regulation.
Topics: Blood Coagulation Disorders; Calciphylaxis; Disease Susceptibility; Humans; Nadroparin; Protein C; P | 1997 |
[Analgesia for childbirth in a patient with factor V Leiden mutation].
Topics: Activated Protein C Resistance; Adult; Analgesia, Epidural; Analgesia, Obstetrical; Anticoagulants; | 2007 |
Diagnosis of APC resistance in patients on standard or low molecular weight heparin.
Topics: Anticoagulants; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Disease Susceptibility; Factor V | 1996 |